Jennifer Carver - Jan 10, 2022 Form 3 Insider Report for REVELATION BIOSCIENCES, INC. (REVB)

Role
Director
Signature
/s/ J.P. Galda, as attorney-in-fact for Jennifer Carver
Stock symbol
REVB
Transactions as of
Jan 10, 2022
Transactions value $
$0
Form type
3
Date filed
1/20/2022, 05:00 PM
Next filing
Apr 18, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding REVB Common Stock 68.1K Jan 10, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding REVB Restricted Stock Unit Jan 10, 2022 Common Stock 21.4K Direct F1, F2, F3
holding REVB Restricted Stock Unit Jan 10, 2022 Common Stock 21.4K Direct F2, F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These RSUs vest quarterly over a four-year period, with the first quarterly vesting scheduled to occur on January 31, 2021.
F2 RSUs do not expire; they either vest or are canceled prior to vesting date.
F3 Each RSU converts into common stock on a one-for-one basis.
F4 These RSUs vest quarterly over a one-year period, with the first quarterly vesting scheduled to occur on May 23, 2021.

Remarks:

Exhibit 24 - Power of Attorney.